Image may be NSFW.
Clik here to view.
WaveForm Technologies said today that it has finished four clinical trials of its continuous glucose monitoring system and that it expects to win CE Mark clearance for the device this year.
The WaveForm CGM system is designed to be worn for 14 days and includes a sensor insertion tool, a small sensor wire, a polymer coating and an on-body transmitter.
Get the full story at our sister site, Drug Delivery Business News.
The post WaveForm touts clinical trial data for continuous glucose monitor appeared first on MassDevice.
